Watson Challenges Cancer

The IBM supercomputer, famous for its game show performance, will aid in cloud-based analyses of genomic data.  

By | March 20, 2014

WIKIMEDIA, CLOCKREADYIBM’s Watson, a supercomputer and one of the most famous “Jeopardy!” champions, will now be deployed in the service of oncologists. The New York Genome Center and IBM this week (March 19) announced a partnership through which Watson will analyze genomic data, with the goal of developing personalized medicine for cancer patients.

“We’re hoping Watson’s learning model can find associations faster than we can and they’ll be able to tune the sets of drugs to at least prioritize and give doctors the ability to drill down so that they can make better determinations of what to try,” Toby Bloom, the deputy scientific director for informatics at the New York Genome Center, told Forbes.

At the outset, Watson will compare genomic data from tumors and non-tumorous tissue from a small group of patients with glioblastoma, a notoriously difficult-to-treat brain cancer. “Time definitely is not on your side when you have glioblastoma and that’s where Watson comes in,” Robert Darnell, the New York Genome Center’s president, CEO, and scientific director, told reporters. John Kelly, a senior vice president and director of IBM Research, told the Associated Press that “Watson can do in seconds what would take people years. And we can get it down to a really personal level.”

According to Forbes, if the initial glioblastoma project is a success, the effort will be scaled up to include more patients.

Add a Comment

Avatar of: You

You

Processing...
Processing...

Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Popular Now

  1. How Gaining and Losing Weight Affects the Body
    Daily News How Gaining and Losing Weight Affects the Body

    Millions of measurements from 23 people who consumed extra calories every day for a month reveal changes in proteins, metabolites, and gut microbiota that accompany shifts in body mass.

  2. That Other CRISPR Patent Dispute
    Daily News That Other CRISPR Patent Dispute

    The Broad Institute and Rockefeller University disagree over which scientists should be named as inventors on certain patents involving the gene-editing technology.

  3. Neurons Use Virus-Like Proteins to Transmit Information
  4. EPO Revokes Broad’s CRISPR Patent
    The Nutshell EPO Revokes Broad’s CRISPR Patent

    Shortly after ruling out the earliest priority dates on a foundational patent for CRISPR gene-editing technology, the European Patent Office rescinded the patent entirely—and more are likely to follow.

AAAS